Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients
T Grantzau, J Overgaard - Radiotherapy and Oncology, 2015 - Elsevier
Background and purpose: Radiotherapy for breast cancer both decreases loco-regional
recurrence rates and improves overall survival. However, radiotherapy has also been …
recurrence rates and improves overall survival. However, radiotherapy has also been …
Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy
Breast cancer radiotherapy represents an essential component in the overall management
of both early stage and locally advanced breast cancer. As the number of breast cancer …
of both early stage and locally advanced breast cancer. As the number of breast cancer …
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer …
Objective To determine whether risk adapted intraoperative radiotherapy, delivered as a
single dose during lumpectomy, can effectively replace postoperative whole breast external …
single dose during lumpectomy, can effectively replace postoperative whole breast external …
Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer
Purpose Second cancer risk after breast conserving therapy is becoming more important
due to improved long term survival rates. In this study, we estimate the risks for develo** a …
due to improved long term survival rates. In this study, we estimate the risks for develo** a …
Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A
E Sperk, G Welzel, A Keller… - Breast cancer research …, 2012 - Springer
The randomized phase III trial TARGIT A showed non-inferiority regarding local control after
intraoperative radiotherapy (IORT 20 Gy which was followed by whole breast radiotherapy …
intraoperative radiotherapy (IORT 20 Gy which was followed by whole breast radiotherapy …
Intraoperative radiotherapy for breast cancer: powerful evidence to change practice
2. Vaidya, JS et al. Long term survival and local control outcomes from single dose targeted
intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer …
intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer …
[HTML][HTML] Pride, prejudice, or science: attitudes towards the results of the TARGIT-A trial of targeted intraoperative radiation therapy for breast cancer
Conflict of interest: Prof JS Vaidya has received a research grant from Photoelectron Corp
(1996–99) and from Carl Zeiss for supporting data management at the University of Dundee …
(1996–99) and from Carl Zeiss for supporting data management at the University of Dundee …
Long-term outcome after intraoperative radiotherapy as a boost in breast cancer
P Matthias, A Keller, W Grit, AM Yasser… - Strahlentherapie …, 2020 - search.proquest.com
Purpose To investigate long-term oncological outcome and incidence of chronic side effects
in patients with breast cancer and intraoperative radiotherapy given as an upfront boost …
in patients with breast cancer and intraoperative radiotherapy given as an upfront boost …
Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, better for healthcare systems
Micro abstract Targeted intraoperative radiotherapy (TARGIT-IORT) is delivered immediately
after lumpectomy for breast cancer. We estimated its impact. At least 44,752 patients with …
after lumpectomy for breast cancer. We estimated its impact. At least 44,752 patients with …
Risk estimation of second primary cancers after breast radiotherapy
Aims: There is evidence towards the induction of second primary cancers (SPCs) after
breast radiotherapy (RT). Organs, such as the lungs and the esophagus, have been …
breast radiotherapy (RT). Organs, such as the lungs and the esophagus, have been …